Sun Pharma Funds $2.5 Million Dermatology Professorship at Mount Sinai
Sun Pharmaceutical Industries Ltd 路 Press Release 路 06 Oct 2026, 11:52 pm
Sun Pharma Funds $2.5 Million Dermatology Professorship at Mount Sinai Sun Pharma announced on 6th Oct'26 the establishment of the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, supported by a $2.5 million endowment. The perpetual endowment funds research, clinical education, and mentorship, with Dr. Mark G. Lebwohl installed as the inaugural professor. As the second-largest U.S. pharmaceutical dermatology company by prescription volume, Sun Pharma reinforces its strategic focus on specialty dermatology, with its Global Innovative Medicines portfolio contributing roughly 22% of total company sales across key therapeutic segments.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
